Financial toxicity in cancer patients undergoing radiotherapy in a universal health care system - a prospective multicenter study of 1075 patients.

[1]  R. Jagsi,et al.  Patient-Reported Financial Toxicity in a Population-Based Cohort of Oropharynx Cancer Survivors. , 2022, International journal of radiation oncology, biology, physics.

[2]  D. Krug,et al.  Finanzielle Toxizität bei Krebspatient*innen unter Strahlentherapie , 2022, Forum.

[3]  M. Pisu,et al.  Navigating financial toxicity in patients with cancer: A multidisciplinary management approach , 2022, CA: a cancer journal for clinicians.

[4]  A. Grosu,et al.  Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study , 2022, Strahlentherapie und Onkologie.

[5]  R. Jagsi,et al.  Financial Toxicity as an End Point in Prospective Clinical Trials Involving Radiation Therapy , 2022, Advances in radiation oncology.

[6]  D. Friedman,et al.  Posttraumatic stress symptoms and financial toxicity among adolescent and young adult oncology patients and their caregivers at cancer diagnosis , 2022, Cancer.

[7]  S. Rai,et al.  Financial Toxicity in Women with Breast Cancer Receiving Radiotherapy: Final Results of a Prospective Observational Study. , 2021, Practical radiation oncology.

[8]  C. Kowalski,et al.  Identifying missing links in the conceptualization of financial toxicity: a qualitative study , 2021, Supportive Care in Cancer.

[9]  P. Hohenberger,et al.  Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa study , 2021, Supportive Care in Cancer.

[10]  J. Berek,et al.  Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors , 2021, Psycho-oncology.

[11]  J. Borrás,et al.  Value-based radiotherapy: A new chapter of the ESTRO-HERO project. , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  P. Lundberg,et al.  Psychological distress and health-related quality of life among women with breast cancer: a descriptive cross-sectional study , 2021, Supportive Care in Cancer.

[13]  P. Duberstein,et al.  Assessment of Financial Toxicity Among Older Adults With Advanced Cancer. , 2020, JAMA network open.

[14]  Stefanos Boukovalas,et al.  Correlation between Financial Toxicity, Quality of Life and Patient Satisfaction in an Insured Population of Breast Cancer Surgical Patients: A Single-Institution Retrospective Study. , 2020, Journal of the American College of Surgeons.

[15]  M. Fitch,et al.  Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review , 2020, Supportive Care in Cancer.

[16]  J. Borrás,et al.  Provision and use of radiotherapy in Europe , 2020, Molecular oncology.

[17]  G. Lyratzopoulos,et al.  Patient Experience Drivers of Overall Satisfaction With Care in Cancer Patients: Evidence From Responders to the English Cancer Patient Experience Survey , 2019, Journal of patient experience.

[18]  D. Sher,et al.  Financial Toxicity and Cancer Therapy: A Primer for Radiation Oncologists. , 2019, Hematology/oncology clinics of North America.

[19]  W. Greiner,et al.  Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  H. Sintonen,et al.  The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients , 2019, Acta oncologica.

[21]  C. Gridelli,et al.  The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  A. Abernethy,et al.  The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. , 2013, The oncologist.

[23]  David Moher,et al.  Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. , 2013, JAMA.

[24]  D. Coyle,et al.  Out-of-pocket costs in the year after early breast cancer among Canadian women and spouses. , 2013, Journal of the National Cancer Institute.

[25]  A. Hinz,et al.  The relationship of quality of life and distress in prostate cancer patients compared to the general population , 2010, Psycho-social medicine.

[26]  E. Erdfelder,et al.  Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses , 2009, Behavior research methods.

[27]  Matthias Egger,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.

[28]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[29]  A. Mehnert,et al.  Die deutsche Version des NCCN Distress-Thermometers , 2006 .

[30]  J Kievit,et al.  The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.